Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
British Journal of Haematology|January 5, 2008
P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cellsJianguo Wen, Haiyun Y Cheng, Yongdong Feng, et al.British Journal of Haematology|November 20, 2008
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trialsJames N George, Susan D Mathias, Ronald S Go, et al.Blood Advances|November 23, 2018
Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopeniaAllyson M Pishko, Sara Fardin, Daniel S Lefler, et al.Leukemia Research|July 18, 2009
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibitionJianguo Wen, Yongdong Feng, Wanting Huang, et al.Journal of Thrombosis and Haemostasis : JTH|July 28, 2019
The risk of major bleeding in patients with suspected heparin-induced thrombocytopeniaAllyson M Pishko, Daniel S Lefler, Phyllis Gimotty, et al.Blood|September 16, 2017
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpuraMarie Scully, Paul Knöbl, Karim Kentouche, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemiaEttore Biagi, Raphael Rousseau, Eric Yvon, et al.Journal of Cardiac Failure|January 15, 2016
Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic ComplicationsPaulino Alvarez, Andrea M Cordero-Reyes, Cesar Uribe, et al.Annals of Hematology|July 8, 2023
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer RegistryEthan A Burns, Justin J Wilson, Sunil Mathur, et al.Journal of Thrombosis and Thrombolysis|June 25, 2005
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committeeE Magnus Ohman, Christopher B Granger, Lawrence Rice, et al.Pageof 7